← Open Payments lookup

KYLE KESSLER: Open Payments

NPI 1649934985 · CLEBURNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,234 in 210 payments from 9 companies in 2025. Trend: 2023 $2,220 · 2024 $2,289 · 2025 $3,234

Food & beverage: $3,114Education: $119
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)47$716
Teva Pharmaceuticals USA, Inc.42$514
Alkermes, Inc.21$485
ABBVIE INC.26$463
E.R. Squibb & Sons, L.L.C.33$329
Otsuka America Pharmaceutical, Inc.20$299
Lundbeck LLC13$212
Neurocrine BioSciences, Inc.7$195
Supernus Pharmaceuticals, Inc.1$21

Products named: CAPLYTA, VRAYLAR, ARISTADA, REXULTI, COBENFY, AUSTEDO XR, INGREZZA, UZEDY.

Industry payments across TX — which companies pay providers there.